Modafinil Ip/bp/usp/ep Medicine Raw Materials

Niksan Pharmaceutical is the largest manufacturer and exporter of the Modafinil among all over the world. Niksan Pharmaceutical is one of biggest the supplier, manufacturer, exporter and distributer of the Modafinil API and finished formulations in Ankleshwar, Gujarat, India. The products of Niksan Pharmaceutical and Niksan group companies are widely appreciated by the clients and other companies.
Niksan pharmaceutical is also large exporter of the API and finished pharmaceutical products of Modafinil in many countries for years. The countries where we exporting are Australia, St Helena, United Kingdom, United States, Ireland, Norway, Canada, Serbia, Singapore, Slovenia, Denmark, Sweden, Romania, Croatia, Netherlands, New Zealand, Czechia, Switzerland, Germany, Austria, South Africa, Belgium, Poland, Lithuania, Philippines, Portugal, Hong Kong, Brazil, United Arab Emirates, Slovakia, Colombia, Hungary, Bulgaria, Pakistan, Mexico, Finland, Israel, Greece, Italy, Egypt, Malaysia, Turkey, Chile, Iran, France, South Korea, Argentina, Vietnam, Spain, Ukraine, Peru, Saudi Arabia, Thailand, Indonesia, Russia, Taiwan, Japan and many other countries.
Niksan Pharmaceutical provides API and finished formulations of Modafinil in all over Indian states Like Kerala, Gujarat, Haryana, Rajasthan, Madhya Pradesh, Uttar Pradesh, Rajasthan, Karnataka, Meghalaya, Tamilnadu, Goa, Sikkim, Assam, Punjab, Delhi, Bihar, Jammu Kashmir Etc.
Modafinil belongs to the medication class called wakefulness promoting agents. Modafinil used to treat narcolepsy, shift work sleep disorders, and sleep apnea. Modafinil helps you to stay awake during the work hours.

SYNONYSMS: Modafinil, Modafinilo, Modafinilum

IUPAC NAME: 2-diphenylmethanesulfinylacetamide

CAS NO: 68693-11-8

FORMULA: C15H15NO2S

MOLECULAR MASS: 273.35 g/mol

STORAGE CONDITIONS: Store in cool and dry place. Keep away from direct light and heat. Do not put medication in bathroom or any humid place. Keep away from children and pets.

HOW TO USE: Take this medication in morning. Take this medication by mouth with or without food once per day. Lower your dose if you feel nausea or vomiting symptoms. Take your doctora s advice if you have any confusion related to the medication.

HOW MODAFINIL WORKS: Modafinil blocks the reuptake dopamine pump and by this the reuptake of dopamine decreased. Modafinil increases the dopamine level in body. Modafinil acts by changing the concentration of dopamine in brains area which controls sleep and wakefulness.

PHARMACOKINETICS: Modafinil rapidly absorbed in body after the oral administration. Modafinil binds with almost 60% of plasma proteins. The half-life of the medicine is between 14-17 hours. Almost 90% of medicine is eliminated by the liver and remaining drug excreted by renal elimination.

SIDE EFFECTS: The common side effects of Modafinil are nausea, vomiting, headache, nervousness, dizziness. Tell your doctor right away if you see effects like fast and irregular heartbeats, depression, hallucination, mental or mood change, confusion. There are some rare allergic reactions like rash, itching, fever swelling of tongue, face, trouble in breathing.

PRECAUTIONS: Tell your doctor if you have allergic reaction to the Modafinil before taking medication. Tell your doctor if you have heart problem, liver problem, kidney problem, chest pain, high blood pressure, mental or mood swings, diabetes or any other problems. This drug makes you dizzy some time so kindly avoid marijuana and alcohol intake. Kindly avoid using the medicine if you are pregnant or in lactation period.

CDSCO APPROVAL: Armodafinil uncoated tablet 50/150/250mg approved by CDSCO in India in 23.04.2010
Modafinil tablets & bulk approved by CDSCO in India in 16.12.2003

FORMULATIONS AVAILABLE IN MARKET:
Modafinil 50 mg tablets
Modafinil 100 mg tablets
Modafinil 150 mg tablets
Modafinil 200 mg tablets
Modafinil 250 mg tablets

Note: Product protected by valid patents are not offered for sale in countries where such patents are still valid and its liability is at Buyers Risk

REFERENCES:

www.webmd.com
https://pubchem.ncbi.nlm.nih.gov
https://go.drugbank.com
https://cdscoonline.gov.in
https://www.wikipedia.org/
https://www.drugs.com
https://www.zaubacorp.com
https://www.practo.com/consult